Can you buy Transcarent stock?

As Transcarent is not publicly traded, purchasing its stock is not available to everyone. To buy the stock of a private company likeTranscarent, you must be an accredited investor . If you meet the accreditation criteria, you can register for Forge’s Secondary Marketplace to buy private market stock. If you are not an accredited investor, discover how to begin the process to potentially qualify for new investment opportunities.

How to buy Transcarent stock?

To invest in a private company like Transcarent through Forge, you must first qualify as an accredited investor. (Learn more about the accreditation process . 1. Create a free account to access Forge’s marketplace. 2. Express your interest in specific investments. Within Forge Markets, you will find detailed pricing and financing information for thousands of private companies. 3. Throughout this process, a dedicated Forge Private Market Specialist will be available to address any questions you may have and to guide you seamlessly through each step of the transaction.

Can you sell Transcarent stock?

Yes, you may be able to sell your Transcarent stock, subject to certain conditions. Forge can help you facilitate the sale of your stock in a manner that aligns with your needs and the company’s interests. If you are looking for liquidity, register with us today to begin the process. A dedicated Forge Private Market Specialist will be available to address any questions you may have along the way.

How to sell Transcarent stock?

If you hold private company shares of Transcarent - whether as an employee or an early investor - Forge can help you sell them. 1. Create a free Forge account, this will give you access to Forge’s marketplace and to one of our experienced Private Market Specialist to answer any questions you might have. 2. Indicate your interest to sell your Transcarent stock on our platform. 3. Work with your dedicated Private Market Specialist who’ll help guide you through every step of the transaction.

Is Transcarent a public company?

No, Transcarent is a privately held company and is currently not publicly traded on any stock markets including NYSE or NASDAQ.

What is Transcarent’s stock price?

Transcarent is a privately held company and therefore does not have a public stock price. However, you may access Transcarent’s private market stock price with Forge Data .

What is Transcarent’s stock ticker symbol?

Transcarent does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.

Invest and Sell Transcarent Stock

Reuters 05/02/2024

Digital health startup Transcarent valued at $2.2 bln after latest funding round

In a series D funding round led by General Catalyst and 7wireVentures, Transcarent raised $126 million.

Business Insider 03/25/2024

Health Startup Transcarent Is Raising a $125 Million

Transcarent is looking to raise $125 million, bringing its valuation to $2.1 billion.

TechCrunch 10/18/2023

Trans healthcare startup Plume lays off dozens of workers

Plume, a US-based telehealth startup focusing on trans healthcare, has reportedly laid off around one-sixth of its workforce. The company raised $24m in a series B funding round last year and offers online healthcare services to transgender patients, a demographic often facing significant healthcare barriers. Despite the layoffs, Plume confirmed it will not scale back its services and plans to expand its fee-for-service offerings.

MedCityNews 09/27/2023

Transcarent Partners With 10 Health Systems To Launch Provider Network

"Transcarent, a care navigation company, has partnered with 10 health systems to launch a new provider network. The network aims to help employer customers provide affordable, high-quality care to their staff. The health systems in the network include Mount Sinai, Mass General Brigham, and Intermountain Health. Transcarent's platform allows patients to access care online, schedule appointments, arrange home visits from providers, access specialists, and order prescription delivery. The company was last valued at $1.62 billion in 2022.

Transcarent Stock

Register To Buy and Sell Shares

Enterprise Value

Access Transcarent’s valuation and stock price.

Transcarent investors also invested in these private companies

Team

Management Team

Board Members

Transcarent stock FAQs